| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.56 | 0.0002 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.51 | 0.0006 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.45 | 0.002 |